ADAR1 Capital Management »

Brighthouse Finl shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Brighthouse Finl (BHF) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Brighthouse Finl

Tip: Access up to 7 years of quarterly data

All positions including Brighthouse Finl held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Brighthouse Finl by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $531k 10k 53.08

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Keros Therapeutics (KROS)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Roivant Sciences SHS (ROIV)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Immunovant (IMVT)
89bio (ETNB)
Zai Lab Adr (ZLAB)
Cytokinetics Com New (CYTK)
Septerna (SEPN)
Uniqure Nv SHS (QURE)
Prothena Corp SHS (PRTA)
Bridgebio Pharma (BBIO)
Arbutus Biopharma (ABUS)

View all positions for ADAR1 Capital Management

Top funds holding Brighthouse Finl

BlackRock
Vanguard Group
Pentwater Capital Management
Dimensional Fund Advisors
UBS Group
DME Capital Management
Susquehanna International
American Century Companies
State Street Corporation
FMR
AQR Capital Management
Balyasny Asset Management
Geode Capital Management
Victory Capital Management
Millennium Management

View all funds holding Brighthouse Finl